Future biomolecular experiments are warranted to study the precise position in IGF2BP2 that SNHG25 (both wild-type and mutant) binds to and the impacts of this binding on recognizing m6A-modified mRNAs in glioblastoma multiforme. The gene discussed is IGF2BP2; the disease is glioblastoma.